Adam Townsend

Chief Operating Officer

As chief operating officer, Adam leads our US and International commercial and medical affairs organizations, and he brings over 20 years of global biopharmaceutical experience in commercial operations and corporate development. From Nov. 2018 – Jan. 2024, Adam was our chief commercial officer, and he built and led our commercial organization as Apellis transitioned to a commercial-stage company with two approved products. Prior to joining Apellis, Adam worked at Biogen with progressive leadership roles in commercial and corporate development, leading the successful launch of multiple blockbuster products in neurology and rare disease. Adam has also held numerous leadership positions with increasing levels of responsibility in Europe at EUSA Pharma and Amgen. Adam began his career in sales at Novartis UK. Adam received a BSc (Hons) degree in medical biochemistry from the University of London, UK.